サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1412800

リードレス心臓ペースメーカーの市場：製品別、エンドユーザー別-2024-2030年の世界予測

Leadless Cardiac Pacemaker Market by Product (Micra Transcatheter Pacing System, Nanostim Leadless Pacemaker), End-User (Academic & Research Institutes, Ambulatory Surgical Centers, Hospitals) - Global Forecast 2024-2030
出版日: | 発行: 360iResearch | ページ情報: 英文 190 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
リードレス心臓ペースメーカーの市場：製品別、エンドユーザー別-2024-2030年の世界予測
出版日: 2024年01月15日
発行: 360iResearch
ページ情報: 英文 190 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

リードレス心臓ペースメーカー市場規模は2023年に2億7,717万米ドルと推定され、2024年には2億9,439万米ドルに達すると予測され、CAGR 7.83%で2030年には4億7,001万米ドルに達する見込みです。

リードレス心臓ペースメーカーの世界市場

主な市場の統計
基準年[2023］ 2億7,717万米ドル
予測年[2024] 2億9,439万米ドル
予測年 [2030] 4億7,001万米ドル
CAGR（%） 7.83%
リードレス心臓ペースメーカー Market-IMG1

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスはリードレス心臓ペースメーカー市場を評価する上で極めて重要です。事業戦略と製品満足度に関連する主要指標を調査し、ベンダーの包括的な評価を提供します。この綿密な分析により、ユーザーは各自の要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功の度合いが異なる4つの象限に分類されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析は、リードレス心臓ペースメーカー市場におけるベンダーの現状について、洞察に満ちた詳細な調査を提供する包括的なツールです。全体的な収益、顧客基盤、その他の主要指標についてベンダーの貢献度を綿密に比較・分析することで、企業の業績や市場シェア争いの際に直面する課題について理解を深めることができます。さらに、この分析により、調査対象基準年に観察された累積、断片化の優位性、合併の特徴などの要因を含む、この分野の競合特性に関する貴重な考察が得られます。このような詳細レベルの拡大により、ベンダーはより多くの情報に基づいた意思決定を行い、市場で競争優位に立つための効果的な戦略を考案することができます。

本レポートは、以下の側面に関する貴重な洞察を提供しています：

1-市場の浸透度：主要企業が提供する市場に関する包括的な情報を提示しています。

2-市場の開拓度：有利な新興市場を深く掘り下げ、成熟市場セグメントにおける浸透度を分析しています。

3-市場の多様化：新製品の発売、未開拓の地域、最近の開発、投資に関する詳細な情報を提供します。

4-競合の評価と情報：市場シェア、戦略、製品、認証、規制状況、特許状況、主要企業の製造能力などを網羅的に評価します。

5-製品開発およびイノベーション：将来の技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような主要な質問に対応しています：

1-リードレス心臓ペースメーカー市場の市場規模および予測は？

2-リードレス心臓ペースメーカー市場の予測期間中に投資を検討すべき製品、セグメント、用途、分野は何か？

3-リードレス心臓ペースメーカー市場における技術動向と規制の枠組みは？

4-リードレス心臓ペースメーカー市場における主要ベンダーの市場シェアは？

5-リードレス心臓ペースメーカー市場への参入に適した形態や戦略的手段は？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 心臓疾患の有病率の上昇
      • ペースメーカーに対する有利な償還政策
      • 術後の合併症や感染症を軽減するための適用性の向上
    • 抑制要因
      • ペースメーカーの技術的限界
    • 機会
      • リードレス心臓ペースメーカーの技術進歩
      • 外来手術センターの発展に向けた投資拡大
    • 課題
      • 厳格な政府政策と熟練した専門家の不足
  • 市場セグメンテーション分析
  • 市場動向分析
  • 高インフレの累積的影響
  • ポーターのファイブフォース分析
  • バリューチェーンとクリティカルパス分析
  • 規制の枠組み

第6章 リードレス心臓ペースメーカーの市場：製品別

  • Micra 経カテーテルペーシングシステム
  • Nanostim リードレスペースメーカー

第7章 リードレス心臓ペースメーカーの市場：エンドユーザー別

  • 学術調査機関
  • 外来手術センター
  • 病院

第8章 南北アメリカのリードレス心臓ペースメーカーの市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第9章 アジア太平洋地域のリードレス心臓ペースメーカーの市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第10章 欧州・中東・アフリカのリードレス心臓ペースメーカーの市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第11章 競合情勢

  • FPNVポジショニングマトリクス
  • 市場シェア分析：主要企業別
  • 競合シナリオ主要企業別の分析

第12章 競争力のあるポートフォリオ

  • 主要な企業プロファイル
    • Abbott Laboratories
    • Boston Scientific Corporation
    • Cairdac
    • Lepu Medical Technology（Beijing）Co., Ltd.
    • Medtronic PLC
    • Vitatron Holding B.V.
  • 主要な製品ポートフォリオ

第13章 付録

  • ディスカッションガイド
  • ライセンスと価格について
図表

LIST OF FIGURES

  • FIGURE 1. LEADLESS CARDIAC PACEMAKER MARKET RESEARCH PROCESS
  • FIGURE 2. LEADLESS CARDIAC PACEMAKER MARKET SIZE, 2023 VS 2030
  • FIGURE 3. LEADLESS CARDIAC PACEMAKER MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. LEADLESS CARDIAC PACEMAKER MARKET DYNAMICS
  • FIGURE 7. LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 8. LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 10. LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. AMERICAS LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 12. AMERICAS LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. UNITED STATES LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 14. UNITED STATES LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. ASIA-PACIFIC LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. ASIA-PACIFIC LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. LEADLESS CARDIAC PACEMAKER MARKET, FPNV POSITIONING MATRIX, 2023
  • FIGURE 20. LEADLESS CARDIAC PACEMAKER MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

  • TABLE 1. LEADLESS CARDIAC PACEMAKER MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. LEADLESS CARDIAC PACEMAKER MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 6. LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY MICRA TRANSCATHETER PACING SYSTEM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY NANOSTIM LEADLESS PACEMAKER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 9. LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. AMERICAS LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 13. AMERICAS LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 14. AMERICAS LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 15. ARGENTINA LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 16. ARGENTINA LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 17. BRAZIL LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 18. BRAZIL LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 19. CANADA LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 20. CANADA LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 21. MEXICO LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 22. MEXICO LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 23. UNITED STATES LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 24. UNITED STATES LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 25. UNITED STATES LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 26. ASIA-PACIFIC LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 27. ASIA-PACIFIC LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 28. ASIA-PACIFIC LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 29. AUSTRALIA LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 30. AUSTRALIA LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 31. CHINA LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 32. CHINA LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 33. INDIA LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 34. INDIA LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 35. INDONESIA LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 36. INDONESIA LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 37. JAPAN LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 38. JAPAN LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 39. MALAYSIA LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 40. MALAYSIA LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 41. PHILIPPINES LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 42. PHILIPPINES LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 43. SINGAPORE LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 44. SINGAPORE LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 45. SOUTH KOREA LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 46. SOUTH KOREA LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 47. TAIWAN LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 48. TAIWAN LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 49. THAILAND LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 50. THAILAND LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 51. VIETNAM LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 52. VIETNAM LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 53. EUROPE, MIDDLE EAST & AFRICA LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 54. EUROPE, MIDDLE EAST & AFRICA LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 55. EUROPE, MIDDLE EAST & AFRICA LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 56. DENMARK LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 57. DENMARK LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 58. EGYPT LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 59. EGYPT LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 60. FINLAND LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 61. FINLAND LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 62. FRANCE LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 63. FRANCE LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 64. GERMANY LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 65. GERMANY LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 66. ISRAEL LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 67. ISRAEL LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 68. ITALY LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 69. ITALY LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 70. NETHERLANDS LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 71. NETHERLANDS LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 72. NIGERIA LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 73. NIGERIA LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 74. NORWAY LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 75. NORWAY LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 76. POLAND LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 77. POLAND LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 78. QATAR LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 79. QATAR LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 80. RUSSIA LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 81. RUSSIA LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 82. SAUDI ARABIA LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 83. SAUDI ARABIA LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 84. SOUTH AFRICA LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 85. SOUTH AFRICA LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 86. SPAIN LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 87. SPAIN LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 88. SWEDEN LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 89. SWEDEN LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 90. SWITZERLAND LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 91. SWITZERLAND LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 92. TURKEY LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 93. TURKEY LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 94. UNITED ARAB EMIRATES LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 95. UNITED ARAB EMIRATES LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 96. UNITED KINGDOM LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED KINGDOM LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 98. LEADLESS CARDIAC PACEMAKER MARKET, FPNV POSITIONING MATRIX, 2023
  • TABLE 99. LEADLESS CARDIAC PACEMAKER MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 100. LEADLESS CARDIAC PACEMAKER MARKET LICENSE & PRICING
目次
Product Code: MRR-2E42D71A2918

[190 Pages Report] The Leadless Cardiac Pacemaker Market size was estimated at USD 277.17 million in 2023 and expected to reach USD 294.39 million in 2024, at a CAGR 7.83% to reach USD 470.01 million by 2030.

Global Leadless Cardiac Pacemaker Market

KEY MARKET STATISTICS
Base Year [2023] USD 277.17 million
Estimated Year [2024] USD 294.39 million
Forecast Year [2030] USD 470.01 million
CAGR (%) 7.83%
Leadless Cardiac Pacemaker Market - IMG1

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Leadless Cardiac Pacemaker Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Leadless Cardiac Pacemaker Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Leadless Cardiac Pacemaker Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Boston Scientific Corporation, Cairdac, Lepu Medical Technology(Beijing)Co., Ltd., Medtronic PLC, and Vitatron Holding B.V..

Market Segmentation & Coverage

This research report categorizes the Leadless Cardiac Pacemaker Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product
    • Micra Transcatheter Pacing System
    • Nanostim Leadless Pacemaker
  • End-User
    • Academic & Research Institutes
    • Ambulatory Surgical Centers
    • Hospitals
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Leadless Cardiac Pacemaker Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Leadless Cardiac Pacemaker Market?

3. What are the technology trends and regulatory frameworks in the Leadless Cardiac Pacemaker Market?

4. What is the market share of the leading vendors in the Leadless Cardiac Pacemaker Market?

5. Which modes and strategic moves are suitable for entering the Leadless Cardiac Pacemaker Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Leadless Cardiac Pacemaker Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of cardiac disorders
      • 5.1.1.2. Favorable reimbursement policies for pacemakers
      • 5.1.1.3. Increasing applicability to reduce postoperative complications and infections
    • 5.1.2. Restraints
      • 5.1.2.1. Technical limitations of pacemakers
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancements in leadless cardiac pacemaker
      • 5.1.3.2. Growing investments for advancement of ambulatory surgical centers
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent governmental policies and scarcity of skilled professionals
  • 5.2. Market Segmentation Analysis
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Leadless Cardiac Pacemaker Market, by Product

  • 6.1. Introduction
  • 6.2. Micra Transcatheter Pacing System
  • 6.3. Nanostim Leadless Pacemaker

7. Leadless Cardiac Pacemaker Market, by End-User

  • 7.1. Introduction
  • 7.2. Academic & Research Institutes
  • 7.3. Ambulatory Surgical Centers
  • 7.4. Hospitals

8. Americas Leadless Cardiac Pacemaker Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Leadless Cardiac Pacemaker Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Leadless Cardiac Pacemaker Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. FPNV Positioning Matrix
  • 11.2. Market Share Analysis, By Key Player
  • 11.3. Competitive Scenario Analysis, By Key Player

12. Competitive Portfolio

  • 12.1. Key Company Profiles
    • 12.1.1. Abbott Laboratories
    • 12.1.2. Boston Scientific Corporation
    • 12.1.3. Cairdac
    • 12.1.4. Lepu Medical Technology(Beijing)Co., Ltd.
    • 12.1.5. Medtronic PLC
    • 12.1.6. Vitatron Holding B.V.
  • 12.2. Key Product Portfolio

13. Appendix

  • 13.1. Discussion Guide
  • 13.2. License & Pricing